Campbell & CO Investment Adviser LLC Raises Stake in Integer Holdings Corporation $ITGR

Campbell & CO Investment Adviser LLC grew its holdings in shares of Integer Holdings Corporation (NYSE:ITGR) by 216.9% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 20,669 shares of the medical equipment provider’s stock after acquiring an additional 14,146 shares during the quarter. Campbell & CO Investment Adviser LLC’s holdings in Integer were worth $2,542,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. SVB Wealth LLC bought a new position in shares of Integer during the 1st quarter valued at $35,000. CWM LLC boosted its position in Integer by 46.1% during the second quarter. CWM LLC now owns 355 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 112 shares during the period. GAMMA Investing LLC grew its stake in shares of Integer by 20.2% during the second quarter. GAMMA Investing LLC now owns 796 shares of the medical equipment provider’s stock valued at $98,000 after buying an additional 134 shares during the last quarter. Headlands Technologies LLC grew its stake in shares of Integer by 1,234.8% during the first quarter. Headlands Technologies LLC now owns 1,228 shares of the medical equipment provider’s stock valued at $145,000 after buying an additional 1,136 shares during the last quarter. Finally, Quantbot Technologies LP purchased a new position in shares of Integer in the first quarter worth about $193,000. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Price Performance

ITGR opened at $68.24 on Monday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.45 and a current ratio of 3.71. The stock has a market capitalization of $2.39 billion, a PE ratio of 28.55, a price-to-earnings-growth ratio of 0.60 and a beta of 0.95. The stock’s 50 day moving average price is $95.47 and its 200-day moving average price is $108.90. Integer Holdings Corporation has a 52-week low of $62.00 and a 52-week high of $146.36.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 EPS for the quarter, topping analysts’ consensus estimates of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.Integer’s revenue was up 8.4% on a year-over-year basis. During the same period last year, the business earned $1.43 earnings per share. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. On average, equities research analysts predict that Integer Holdings Corporation will post 6.01 EPS for the current year.

Integer announced that its Board of Directors has approved a stock buyback program on Tuesday, November 4th that authorizes the company to repurchase $200.00 million in shares. This repurchase authorization authorizes the medical equipment provider to repurchase up to 8.3% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board of directors believes its stock is undervalued.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on ITGR. Citigroup dropped their target price on Integer from $77.00 to $69.00 and set a “neutral” rating for the company in a report on Monday, November 3rd. Benchmark reiterated a “hold” rating on shares of Integer in a research report on Friday, October 24th. Bank of America lowered Integer from a “buy” rating to a “neutral” rating and set a $87.00 price objective for the company. in a research note on Friday, October 24th. KeyCorp cut their target price on shares of Integer from $145.00 to $133.00 and set an “overweight” rating on the stock in a report on Tuesday, October 21st. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Integer in a report on Friday, October 31st. Four investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $96.75.

Insider Buying and Selling at Integer

In related news, CEO Payman Khales purchased 3,127 shares of Integer stock in a transaction that occurred on Thursday, October 30th. The shares were bought at an average price of $64.94 per share, for a total transaction of $203,067.38. Following the completion of the transaction, the chief executive officer directly owned 22,865 shares of the company’s stock, valued at $1,484,853.10. This represents a 15.84% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 2.16% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.